Your Article Summary
See Latest ArticlesTo lower or not to lower? Making sense of the latest research on intensive glycaemic control and cardiovascular outcomes
Evidence-Based Medicine, 06/10/09
Sherifali D et al. - Diabetes is an extremely burdensome and costly chronic disease. It affects an estimated 4–6% of the world’s population, and its prevalence continues to rise. Diabetes is a major cause of blindness, end stage renal disease, and cardiovascular complications, all of which are preventable. Clinical practice guidelines for the management of diabetes emphasise the importance of optimal glycaemic control. Specifically, some clinical practice guidelines have suggested targeting a glycated haemoglobin (Hb) A1c concentration <=7%, or <=6% for those able to safely achieve it.
Today in General Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Approach to Thrombocytopenia in Older Adults
Geriatrics & Aging, 11/10/09
Beyond office sphygmomanometry: Ways to better assess blood pressure
Cleveland Clinic Journal of Medicine, 11/03/09
Vitamin D: An Evidence-Based Review
Journal of the American Board of Family Medicine, 11/09/09
Today in Preventive Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/21/09
Homocysteine lowering interventions for preventing cardiovascular events
Cochrane Reviews, 10/19/09
Antithrombotic medication for stroke prevention
Expert Review of Cardiovascular Therapy , 10/20/09